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Neurofibromatosis type I (NF1) is one of the most common
autosomal dominant disorders in man and is characterized by
caff-au-Hut spots, multiple neurofibromas, iris hamartomas (lisch
nodules), orthopedic problems, learning disabilities, and an
increased risk of malignancy. TheNFl gene consists of 49 exons,
and extends over a genomic distance of approximately 300 kb
on human chromosome 17ql 1.2. It encodes for neurofibromin,
a 2818 amino acid protein which is capable of down-regulating
ras by stimulating its intrinsic GTPase activity (1-4) . The
mutation rate for NF1 is high (1 in 10 000), and about half of
all cases are due to new mutations (5). In order to characterize
the individual mutations in the NF1 gene, we investigated
genomic DNA samples from 82 Swiss NF1 families (including
31 sporadic cases) by single strand conformation polymorphism
(SSCP) analysis. Here we describe two novel mutations found
in exons 28 and 31 of the NF1 gene. The other 80 families
investigated for these two exons showed no SSCP alterations.
Exon 28 and exon 31 were amplified by the polymerase chain
reation (PCR) using primers described by Upadhyaya etal (5)
and Cawthon et al. (2) on a Perkin Elmer 9600 thermal cycler.
For exon 28, PCR was performed at 94°C for 1 min followed
by 30 cycles at 94°C 30 sec, 52°C 30 sec, and 72°C 30 sec,
with final elongation at 72°C for 10 min. For exon 31, the
amplification conditions were: 94°C for 1 min, then 30 cycles
at 94°C 30 sec, 50°C 15 sec, 72°C 15 sec, with final elongation
at 72°C for 10 min. SSCP was performed following the method
of Yap etaL(6): Briefly, 2 - 1 0 ^1 of PCR product was adjusted
to a total volume of 10 /il with water, incubated at 42°C for 10
min after addition of 1 /d 0.5 M NaOH, 10 mM EDTA. 1 /tl
of formamide containing 0.5% bromophenol blue and 0.5%
xylene cyanol was added just before loading. Electrophoresis was
carried out on 5—6% polyacrylamide gels either with 10%
glycerol at 20°C or without glycerol at 4°C. The gels were run
at 400-500 volts (20-25 V/cm) for 4 hours. Bands were
visualized by silver staining. Double-stranded PCR products
purified by agarose gel electrophoresis were sequenced using
Sequenase version 2.0 (USB) under the conditions described by
Casanova et al (7).
Every affected individual in NF1 family 15 showed one
aberrant single strand band and one aberrant double strand band
in exon 28 by SSCP analysis. Direct sequencing of the PCR-
product revealed an ' A C deletion at codon 1703 (5108delAG).
This deletion leads to a shift of the reading frame, creates a stop
codon 93 bases downstream, and thus should result in a truncated
gene product of 1733 amino acids (see Figure 1). One aberrant
single strand band segregating with the disease phenotype in NF1
family 72 was detected in exon 31 by SSCP analysis. Sequence
analysis revealed a guanine insertion at codon 1939 (5816insG),
which also leads to a frameshift resulting in a stop codon 7 bases
downstream, predicting a truncated protein of 1941 amino acids
(see Figure 2). This mutation abolishes a CviR I restriction site.
The adult patients 49 and 51 of NF1 family 15 suffer from
a very severe dermal form of NF1 with extensive involvement
of trunk, neck and face. Individual 47 of the same family
developed multiple dermal neurofibromas before puberty, and
has left-sided tibia pseudoarthrosis and one plexiform
neurorofibroma causing extreme hypertrophy of the right foot.
All patients present with mild to severe funnel chest. Common
clinical features shared by the patients of NF1 family 72 include
multiple caft-au-laU spots, and dermal and subcutaneous
neurofibromas. In addition, patient 332 and her affected brother,
who has not been investigated by molecular studies, suffer from
severe scohosis. In patients 328 and 326, no spine deformity has
been found.
Only a few mutations have been previously identified in the
NF1 gene. Of the mutations presented here, 5108delAG is
associated with very severe dermal manifestations and funnel
chest in NF1 family 15, and 5816insG with severe scoliosis in
2 out of 4 affected members from NF1 family 72. Interestingly,
three other previously reported families carrying nonsense
mutations in exon 31 also exhibited scohosis (8, 9), suggesting
a possible correlation between this clinical feature and these
particular mutations. It will be important to identify a larger
number of mutations in NF1 patients in order to clarify the
phenotypic consequences of mutations in specific gene regions.
The identification of these mutations is also helpful for genetic
counselling and diagnosis of affected individuals and
asymptomatic gene carriers in the respective families.
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